Kinase pathways are also deregulated in neuroblastoma, including activating mutations of ALK [11], increased Akt signalling in stage 3 and 4 neuroblastoma [12], and relapsing neuroblastomas displaying mutations in the Ras-MAPK pathway [13], [14]. This evidence concerns the gene AKT1 and neuroblastoma.